BLUEJETBSEBlue Jet Healthcare LtdLowNeutral
Announced Tue, 19 May · 12:00 IST

Intimation of earnings call

Board & Shareholder Meetings View source PDF

BLUEJET · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.3%1-day move
₹420.00
prior close
₹436.65
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.1+0.4+1.0+3.3+5.1+4.5+15.2+18.8+7.9+11.7+22.3+40.1
Up moveDown movePending
AI summary

Blue Jet Healthcare Ltd has scheduled a conference call on Monday, May 25, 2026 at 4:00 PM IST to discuss its audited standalone financial results for Q4 and the financial year ended March 31, 2026. The company's management, including MD Shiven Arora, COO V.K. Singh, CFO Ganesh Karuppannan, and Deputy CFO Sanjay Sinha, will participate in the call. The company is a CDMO (Contract Development and Manufacturing Organization) specializing in pharmaceutical intermediates for contrast media and high-intensity sweeteners, serving global clients including GE Healthcare, Guerbet, Bracco, Colgate Palmolive, and Unilever. This filing is made under SEBI Regulation 30 for timely disclosure to the exchanges.

Likely market impact

This is a routine regulatory filing announcing an upcoming earnings release and management commentary. The call date gives investors a clear timeline for when Q4/FY26 results and forward-looking statements will be available, which could influence near-term stock sentiment ahead of the actual disclosure.